Capital World Investors
AGL icon

Capital World Investors’s Agilon Health AGL Stock Holding History

Capital World Investors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-334,569
Closed -$5.76M – 624
2025
Q4 		$5.76M Hold
334,569
– – ﹤0.01% 517
2025
Q3 		$8.62M Sell
334,569
-1,488,255
-82% -$56.2M ﹤0.01% 504
2025
Q2 		$105M Sell
1,822,824
-313,453
-15% -$25.1M 0.02% 340
2025
Q1 		$231M Buy
2,136,277
+283,948
+15% +$24.7M 0.04% 258
2024
Q4 		$88M Sell
1,852,329
-82,391
-4% -$4.98M 0.01% 354
2024
Q3 		$190M Sell
1,934,720
-118,169
-6% -$15.3M 0.03% 287
2024
Q2 		$336M Buy
2,052,889
+356,978
+21% +$50.9M 0.05% 232
2024
Q1 		$259M Sell
1,695,911
-512,829
-23% -$85.3M 0.04% 263
2023
Q4 		$693M Buy
2,208,740
+152,529
+7% +$55.2M 0.12% 162
2023
Q3 		$913M Buy
2,056,211
+2,307
+0.1% +$1.04M 0.18% 126
2023
Q2 		$890M Buy
2,053,904
+356,465
+21% +$200M 0.17% 134
2023
Q1 		$1.01B Buy
1,697,439
+180,700
+12% +$101M 0.21% 125
2022
Q4 		$612M Buy
1,516,739
+139,397
+10% +$65.4M 0.13% 160
2022
Q3 		$806M Buy
1,377,342
+42,893
+3% +$25.7M 0.18% 137
2022
Q2 		$728M Sell
1,334,449
-118,447
-8% -$59.9M 0.15% 148
2022
Q1 		$921M Buy
1,452,896
+18,258
+1% +$9.41M 0.16% 152
2021
Q4 		$968M Buy
1,434,638
+164,950
+13% +$100M 0.15% 143
2021
Q3 		$809M Buy
1,269,688
+130,497
+11% +$111M 0.14% 164
2021
Q2 		$1.05B Buy
+1,139,191
New +$998M 0.18% 133

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Capital World Investors's AGL Position: Q1 2026 in Review

Capital World Investors sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 334,569 shares — an estimated $5.76M sold.

Capital World Investors first reported a position in AGL in Q2 2021 and held it in 19 quarters. The position peaked at $1.05B in Q2 2021. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Capital World Investors reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Capital World Investors sold 334,569 Agilon Health shares in Q1 2026, an estimated $5.76M.
  • Capital World Investors first reported a position in Agilon Health in Q2 2021 and held it in 19 quarters.
  • Capital World Investors's Agilon Health position peaked at $1.05B in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.